What's New on the FDA Drugs Site
May 18, 2016
- Drugs@FDA Data Files (updated)
- eCTD Important Notices (updated)
- Electronic Common Technical Document (eCTD) (updated)
- Information on Clozapine (updated)
- FDA Drug Safety Communication:Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate
- FDA approves Tecentriq (atezolizumab), a new, targeted treatment for bladder cancer
- Medication Guides (updated)
- Well Care Compounding Pharmacy Issues Voluntary Statewide Recall of All Sterile Compounded Products Due to Lack Of Assurance if Sterility Concerns
.png)
No hay comentarios:
Publicar un comentario